Diabetes Care, Vol 17, Issue 12 1422-1427, Copyright © 1994 by American Diabetes Association

ARTICLES

Peripheral autonomic impairment in patients newly diagnosed with type II diabetes

EA McDaid, B Monaghan, AI Parker, JR Hayes and JA Allen
Department of Physiology, Queen's University of Belfast, U.K.

OBJECTIVE--To measure both peripheral and central autonomic function in patients newly diagnosed with type II diabetes. RESEARCH DESIGN AND METHODS--Measurements were made on 49 diabetic patients (8 with long-standing diabetes and neuropathic complications, 41 with newly diagnosed type II diabetes) and on 49 healthy, age- and sex-matched, control subjects. Five of the 41 newly diagnosed type II diabetic patients had retinopathy, and 4 had clinical evidence of neuropathy. No patient or control subject had significant vascular disease. Cardiac autonomic function was investigated by using standard cardiovascular reflex tests. The digital vasoconstrictor responses to deep breathing and body cooling were measured using venous occlusion plethysmography. RESULTS--The vasoconstrictor responses to a deep breath and body cooling were significantly reduced (P < 0.001) in the fingers and toes of the neuropathic patients compared with their matched control subjects, as were the heart rate responses (P < 0.02). The vasoconstrictor responses were significantly reduced in the toes (P < 0.001) and fingers (P < 0.05, P < 0.01) of the newly diagnosed patients compared with the corresponding responses in the control subjects. There was no significant difference in the heart rate or blood pressure responses of these patients and control subjects during standard tests of cardiac autonomic function. CONCLUSIONS--Patients with type II diabetes may have impaired peripheral autonomic function at diagnosis.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. F. B. Morrison, S. Shehab, R. Sheen, S. Dhanasekaran, M. Shaffiullah, and E. Mensah-Brown Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes Exp Physiol, February 1, 2008; 93(2): 213 - 222. [Abstract] [Full Text] [PDF]

				M. A. Creager, T. F. Luscher, F. Cosentino, and J. A. Beckman Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I Circulation, September 23, 2003; 108(12): 1527 - 1532. [Full Text] [PDF]

				J. A. Beckman, M. A. Creager, and P. Libby Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA, May 15, 2002; 287(19): 2570 - 2581. [Abstract] [Full Text] [PDF]